Vijay Shankaran has been a security analyst/portfolio manager at Turner Investment Partners since 2006. He has nine years of investment experience and covers stocks in the healthcare sector.

Prior to joining Turner Investment Partners, Mr. Shankaran was employed by Caxton Associates, MedImmune, Inc., and RiverVest Ventures.

Mr. Shankaran graduated magna cum laude with honors from Dartmouth College with an AB in Chemistry. He then received his MD and PhD in Immunology from Washington University School of Medicine and received his MBA with honors from the Wharton School of Business at the University of Pennsylvania. Mr. Shankaran is an affiliate member of the CFA Institute and the CFA Society of Philadelphia.

Turner Investment Partners is an employee-owned investment-management firm based in Berwyn, Pennsylvania. As of September 30, 2008, the firm managed approximately $22.2 billion in domestic equity investments for institutions and high net worth individuals.

Aesthetic medicine: a booming (and boomer) market

Will plasma products' prospects remain sunny?

Contract research helps keep drug pipeline flowing